222 related articles for article (PubMed ID: 10337026)
1. Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism.
Huang YH; Schäfer-Elinder L; Wu R; Claesson HE; Frostegård J
Clin Exp Immunol; 1999 May; 116(2):326-31. PubMed ID: 10337026
[TBL] [Abstract][Full Text] [Related]
2. Platelet-activating factor and oxidized LDL induce immune activation by a common mechanism.
Frostegård J; Huang YH; Rönnelid J; Schäfer-Elinder L
Arterioscler Thromb Vasc Biol; 1997 May; 17(5):963-8. PubMed ID: 9157962
[TBL] [Abstract][Full Text] [Related]
3. Oxidised LDL modulates immune-activation by an IL-12 dependent mechanism.
Fei GZ; Huang YH; Swedenborg J; Frostegård J
Atherosclerosis; 2003 Jul; 169(1):77-85. PubMed ID: 12860253
[TBL] [Abstract][Full Text] [Related]
4. Oxidized low density lipoproteins downregulate LPS-induced platelet-activating factor receptor expression in human monocyte-derived macrophages: implications for LPS-induced nuclear factor-kappaB binding activity.
Hourton D; Stengel D; Chapman MJ; Ninio E
Eur J Biochem; 2001 Aug; 268(16):4489-96. PubMed ID: 11502209
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidylcholine is involved in the antigenicity of oxidized LDL.
Wu R; Huang YH; Elinder LS; Frostegård J
Arterioscler Thromb Vasc Biol; 1998 Apr; 18(4):626-30. PubMed ID: 9555869
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidylcholine transduces Ca2+ signaling via the platelet-activating factor receptor in macrophages.
Ogita T; Tanaka Y; Nakaoka T; Matsuoka R; Kira Y; Nakamura M; Shimizu T; Fujita T
Am J Physiol; 1997 Jan; 272(1 Pt 2):H17-24. PubMed ID: 9038918
[TBL] [Abstract][Full Text] [Related]
7. Platelet-Activating Factor Deteriorates Lysophosphatidylcholine-Induced Demyelination Via Its Receptor-Dependent and -Independent Effects.
Tian Z; Chu T; Shields LBE; Zhu Q; Zhang YP; Kong M; Barnes GN; Wang Y; Shields CB; Cai J
Mol Neurobiol; 2020 Oct; 57(10):4069-4081. PubMed ID: 32661728
[TBL] [Abstract][Full Text] [Related]
8. Expression of the PAF receptor in human monocyte-derived macrophages is downregulated by oxidized LDL: relevance to the inflammatory phase of atherogenesis.
Stengel D; Antonucci M; Arborati M; Hourton D; Griglio S; Chapman MJ; Ninio E
Arterioscler Thromb Vasc Biol; 1997 May; 17(5):954-62. PubMed ID: 9157961
[TBL] [Abstract][Full Text] [Related]
9. Oxidized LDL induces enhanced antibody formation and MHC class II-dependent IFN-gamma production in lymphocytes from healthy individuals.
Huang YH; Rönnelid J; Frostegård J
Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1577-83. PubMed ID: 7583530
[TBL] [Abstract][Full Text] [Related]
10. Oxidized LDL suppresses NF-kappaB and overcomes protection from apoptosis in activated endothelial cells.
Heermeier K; Leicht W; Palmetshofer A; Ullrich M; Wanner C; Galle J
J Am Soc Nephrol; 2001 Mar; 12(3):456-463. PubMed ID: 11181793
[TBL] [Abstract][Full Text] [Related]
11. Synergism between platelet-activating factor-like phospholipids and peroxisome proliferator-activated receptor gamma agonists generated during low density lipoprotein oxidation that induces lipid body formation in leukocytes.
de Assis EF; Silva AR; Caiado LF; Marathe GK; Zimmerman GA; Prescott SM; McIntyre TM; Bozza PT; de Castro-Faria-Neto HC
J Immunol; 2003 Aug; 171(4):2090-8. PubMed ID: 12902515
[TBL] [Abstract][Full Text] [Related]
12. Structural and functional analysis of a platelet-activating lysophosphatidylcholine of Trypanosoma cruzi.
Gazos-Lopes F; Oliveira MM; Hoelz LV; Vieira DP; Marques AF; Nakayasu ES; Gomes MT; Salloum NG; Pascutti PG; Souto-Padrón T; Monteiro RQ; Lopes AH; Almeida IC
PLoS Negl Trop Dis; 2014 Aug; 8(8):e3077. PubMed ID: 25101628
[TBL] [Abstract][Full Text] [Related]
13. Oxidative modification of low-density lipoproteins and the inhibition of relaxations mediated by endothelium-derived nitric oxide in rabbit aorta.
Plane F; Bruckdorfer KR; Kerr P; Steuer A; Jacobs M
Br J Pharmacol; 1992 Jan; 105(1):216-22. PubMed ID: 1596684
[TBL] [Abstract][Full Text] [Related]
14. Temporary membrane distortion of vascular smooth muscle cells is responsible for their apoptosis induced by platelet-activating factor-like oxidized phospholipids and their degradation product, lysophosphatidylcholine.
Kogure K; Nakashima S; Tsuchie A; Tokumura A; Fukuzawa K
Chem Phys Lipids; 2003 Nov; 126(1):29-38. PubMed ID: 14580708
[TBL] [Abstract][Full Text] [Related]
15. Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis.
Bussolino F; Arese M; Montrucchio G; Barra L; Primo L; Benelli R; Sanavio F; Aglietta M; Ghigo D; Rola-Pleszczynski MR
J Clin Invest; 1995 Aug; 96(2):940-52. PubMed ID: 7543496
[TBL] [Abstract][Full Text] [Related]
16. Comparative toxicity of oxidatively modified low-density lipoprotein and lysophosphatidylcholine in cultured vascular endothelial cells.
Naito M; Yamada K; Hayashi T; Asai K; Yoshimine N; Iguchi A
Heart Vessels; 1994; 9(4):183-7. PubMed ID: 7961295
[TBL] [Abstract][Full Text] [Related]
17. Antibodies against lysophosphatidylcholine and oxidized LDL in patients with SLE.
Wu R; Svenungsson E; Gunnarsson I; Andersson B; Lundberg I; Schäfer Elinder L; Frostegård J
Lupus; 1999; 8(2):142-50. PubMed ID: 10192509
[TBL] [Abstract][Full Text] [Related]
18. Effect of lysophosphatidylcholine on the structure and function of low density lipoproteins.
Korotaeva AA; Cheglakov IB; Morozkin AD; Suslova IV; Prokazova NV
Membr Cell Biol; 1997; 10(5):521-34. PubMed ID: 9225256
[TBL] [Abstract][Full Text] [Related]
19. Platelet-activating factor receptor mediates oxidized low density lipoprotein-induced migration of bone marrow-derived mesenchymal stem cells.
Shin SH; Song HY; Kim MY; Do EK; Kim KH; Kim JH
Cell Physiol Biochem; 2010; 26(4-5):689-98. PubMed ID: 21063106
[TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidylcholine activates p38 and p42/44 mitogen-activated protein kinases in monocytic THP-1 cells, but only p38 activation is involved in its stimulated chemotaxis.
Jing Q; Xin SM; Zhang WB; Wang P; Qin YW; Pei G
Circ Res; 2000 Jul; 87(1):52-9. PubMed ID: 10884372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
